Search
for
Sort by
Research 271–300 of 1000+
- Research Progress in Chronic Autoimmune Urticaria
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Treatment of pediatric alopecia areata: A systematic review
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- INTERFERONS IN DERMATOLOGY
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- New therapies for alopecia areata
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Emerging treatments in alopecia
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity